MB, Levis & Associates’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431 | Hold |
100
| – | – | ﹤0.01% | 257 |
|
|
2025
Q1 | $374 | Hold |
100
| – | – | ﹤0.01% | 270 |
|
|
2024
Q4 | $1.01K | Hold |
100
| – | – | ﹤0.01% | 266 |
|
|
2024
Q3 | $1.25K | Hold |
100
| – | – | ﹤0.01% | 263 |
|
|
2024
Q2 | $1.3K | Hold |
100
| – | – | ﹤0.01% | 260 |
|
|
2024
Q1 | $2.27K | Hold |
100
| – | – | ﹤0.01% | 251 |
|
|
2023
Q4 | $1.3K | Hold |
100
| – | – | ﹤0.01% | 248 |
|
|
2023
Q3 | $2.01K | Hold |
100
| – | – | ﹤0.01% | 247 |
|
|
2023
Q2 | $2.69K | Hold |
100
| – | – | ﹤0.01% | 238 |
|
|
2023
Q1 | $5.84K | Hold |
100
| – | – | ﹤0.01% | 216 |
|
|
2022
Q4 | $5.1K | Buy |
+100
| New | +$5.1K | ﹤0.01% | 207 |
|